Isolde Frieling

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos et al. · The Lancet Diabetes & Endocrinology · 2019 · 164 citations

Bone Disease, Osteopathy, Loft Extension Study +10

Bone health and fracture rate in individuals with neurofibromatosis 1 (NF1)

T Tucker, Claudia Schnabel, M. Hartmann et al. · Journal of Medical Genetics · 2008 · 105 citations

Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study

Peyman Hadji, Evelien Gielen, Maurille Feudjo Tepie et al. · Osteoporosis International · 2015 · 92 citations · Full text

Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis

René Rizzoli, Roland Chapurlat, J.-M. Laroche et al. · Osteoporosis International · 2011 · 86 citations · Full text

Physiology, Bone Microstructure, Gynecology +9

Strontium ranelate and alendronate have differing effects on distal tibia bone microstructure in women with osteoporosis

René Rizzoli, Michel Laroche, Marc-Antoine Krieg et al. · Rheumatology International · 2010 · 80 citations · Full text